Democratic
presidential frontrunner Hillary Clinton called him an outrageous drug
“price gouger.” GOP frontrunner Donald Trump dismissed him as “a spoiled
brat.” And Sen. Bernie Sanders rejected his campaign contribution as
soiled money.
Martin Shkreli, the cocky, 32-year-old former Wall Street hedge fund manager and owner of Turing Pharmaceuticals, caused a national furor recently after he acquired the rights to a drug called Daraprim for treating parasitic infections and then jacked up the price by 5,000 percent – from $13.50 a tablet to $750.
Related: The Feds Finally Make a Move on Soaring Drug Prices
The drug has been on the market for more than 60 years, and the Infectious Disease Society of America and others have estimated that it would cost $336,000 a year to treat someone with toxoplasmosis at $750 per pill, according to reports.
Read More Here
Martin Shkreli, the cocky, 32-year-old former Wall Street hedge fund manager and owner of Turing Pharmaceuticals, caused a national furor recently after he acquired the rights to a drug called Daraprim for treating parasitic infections and then jacked up the price by 5,000 percent – from $13.50 a tablet to $750.
Related: The Feds Finally Make a Move on Soaring Drug Prices
The drug has been on the market for more than 60 years, and the Infectious Disease Society of America and others have estimated that it would cost $336,000 a year to treat someone with toxoplasmosis at $750 per pill, according to reports.
No comments:
Post a Comment
Hello and thank you for visiting my blog. Please share your thoughts and leave a comment :)